OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Ryan on the Unblinding of the COU-AA-302 Trial

August 13th 2012

Dr. Charles Ryan from the UCSF Helen Diller Family Comprehensive Cancer Center Discusses the Unblinding of the COU-AA-302 Trial

Paul Jacobsen Discusses Survivorship Care Plans

August 10th 2012

Paul Jacobsen, from the H. Lee Moffitt Cancer Center and Research Institute, Discusses Survivorship Care Plans

Dr. Gandara Discusses Molecular Testing for NSCLC

August 9th 2012

Dr. David Gandara, from University of California, Davis Comprehensive Cancer Center, discusses using the multiplexing assay for patients with non-small cell lung cancer

Dr. Ambinder on the Potential Impact of SIRI on Health IT

August 8th 2012

Dr. Edward Ambinder, from Mount Sinai School of Medicine, on the Potential Impact of using Apple's SIRI to aid Health Information Technology.

Dr. Krychman on the Awareness of Sexual Health Concerns

August 7th 2012

Dr. Michael Krychman, from he Southern California Center for Sexual Health and Survivorship Medicine, Discusses the Awareness of Sexual Health Concerns in Breast Cancer Patients.

Dr. Sandler on Immunotherapies to Treat Lung Cancer

August 2nd 2012

Dr. Alan Sandler from the Oregon Health & Science University Discusses Immunotherapies for Lung Cancer

Dr. Crawford Discusses Managing Cancer Cachexia

August 1st 2012

Dr. Jeffrey Crawford from Duke University Medical Center Discusses Managing Cancer-Related Cachexia

Dr. Foley Addresses the Importance of Palliative Care

July 31st 2012

Dr. Kathleen Foley, from Memorial Sloan-Kettering Cancer Center, Addresses the Importance of Palliative Care

Dr. Gralow Discusses T-DM1-Induced Thrombocytopenia

July 31st 2012

Dr. Julie Gralow from the Seattle Cancer Care Alliance Discusses T-DM1-Induced Thrombocytopenia

Dr. Rummel on the Chemical Structure of Bendamustine

July 30th 2012

Dr. Mathias Rummel, from the University Hospital Giessen in Germany, on the Bendamustine Chemical Structure

Donna Berry on Symptom Distress and Adherence

July 27th 2012

Donna L. Berry, from Dana-Farber Cancer Institute, on Symptom Distress and Oral Therapy Adherence.

Dr. Cohen Discusses Treating Medullary Thyroid Cancer

July 26th 2012

Dr. Ezra Cohen, from the University of Chicago, Discusses Treating Medullary Thyroid Cancer

Dr. Hesketh on Developing Guidelines and Protocols

July 25th 2012

Dr. Paul J. Hesketh, from Lahey Clinic Medical Center, on Developing Guidelines and Protocols

Dr. Ewer Discusses Supportive Care

July 24th 2012

Dr. Michael S. Ewer, from The University of Texas MD Anderson Cancer Center, on Supportive Care

Dr. Rotkowitz Defines Personalized Medicine

July 23rd 2012

Dr. Michael Rotkowitz, from Cancer Treatment Centers of America, Defines Personalized Medicine

Joseph Unger on Low-Income Clinical Trial Participation

July 20th 2012

Joseph Unger, from the SWOG Statistical Center at the Fred Hutchinson Cancer Research Center, on Low-Income Clinical Trial Participation.

Dr. Gralla on Future Advances in CINV Prevention

July 20th 2012

Dr. Richard Gralla, from Quality of Life Research Associates, on Future Advances in chemotherapy-induced nausea and vomiting Prevention

Carrie Stricker on Barriers to Adopting Triple Therapy

July 19th 2012

Carrie Stricker, PhD, RN, from Abramson Cancer Center, on Barriers to Adopting Triple Therapy

Dr. Grunberg on Barriers to Effective Supportive Care

July 19th 2012

Steven M. Grunberg, MD, University of Vermont, on Barriers to Providing Effective Supportive Care for Patients with Cancer.

Dr. Bast Discusses Biomarkers for Ovarian Cancer

July 19th 2012

Dr. Robert Bast, from the MD Anderson Cancer Center, Discusses New Biomarker Panels for Ovarian Cancer Screening.